Our results indicating that its use in therapeutic doses in myocarditis by blocking the RhoA/ROCK pathway and the previously demonstrated blocking of MMP 9 activation and beneficial effect on the course of inflammation indicate that its repurposing may constitute a promising and very attractive option. The gene discussed is RHOA; the disease is myocarditis.